Keywords: isentress, plus, obt, sustains, hiv, suppression, usa-based

Isentress plus OBT sustains HIV suppression

Article | 01 October 2007

Print This

USA-based Merck & Co says that data from an ongoing Phase II study showed that antiretroviral suppression was sustained after 48 weeks ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in